William C. Ballard, Jr. Sells 5,000 Shares of UnitedHealth Group Inc (UNH) Stock

UnitedHealth Group Inc (NYSE:UNH) Director William C. Ballard, Jr. sold 5,000 shares of the company’s stock in a transaction on Tuesday, January 22nd. The stock was sold at an average price of $266.61, for a total transaction of $1,333,050.00. Following the transaction, the director now directly owns 77,702 shares in the company, valued at $20,716,130.22. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Shares of UNH stock traded up $1.26 during trading hours on Wednesday, hitting $266.95. 113,193 shares of the company’s stock were exchanged, compared to its average volume of 3,612,149. The company has a debt-to-equity ratio of 0.64, a quick ratio of 0.69 and a current ratio of 0.73. The stock has a market capitalization of $255.42 billion, a PE ratio of 20.68, a PEG ratio of 1.36 and a beta of 0.88. UnitedHealth Group Inc has a 52 week low of $208.48 and a 52 week high of $287.94.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, January 15th. The healthcare conglomerate reported $3.28 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.20 by $0.08. UnitedHealth Group had a return on equity of 24.38% and a net margin of 5.30%. The business had revenue of $58.42 billion for the quarter, compared to analyst estimates of $58.01 billion. During the same quarter in the prior year, the firm posted $2.59 earnings per share. The firm’s revenue for the quarter was up 12.2% compared to the same quarter last year. As a group, analysts forecast that UnitedHealth Group Inc will post 14.62 earnings per share for the current fiscal year.

UNH has been the topic of a number of research reports. Bank of America increased their price objective on shares of UnitedHealth Group from $315.00 to $320.00 and gave the company a “buy” rating in a research note on Wednesday, October 17th. Raymond James increased their price objective on shares of UnitedHealth Group from $304.00 to $310.00 and gave the stock a “strong-buy” rating in a report on Wednesday, October 17th. ValuEngine upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Tuesday, October 2nd. Argus raised their price target on shares of UnitedHealth Group from $285.00 to $295.00 and gave the company a “buy” rating in a report on Monday, December 17th. Finally, Jefferies Financial Group lifted their price objective on shares of UnitedHealth Group from $270.00 to $311.00 and gave the company a “buy” rating in a research note on Wednesday, October 3rd. One research analyst has rated the stock with a hold rating and twenty-two have given a buy rating to the company. UnitedHealth Group has an average rating of “Buy” and a consensus price target of $295.80.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in UNH. Vanguard Group Inc. lifted its position in shares of UnitedHealth Group by 1.6% in the third quarter. Vanguard Group Inc. now owns 69,342,549 shares of the healthcare conglomerate’s stock valued at $18,447,892,000 after buying an additional 1,073,505 shares during the last quarter. Vanguard Group Inc increased its stake in shares of UnitedHealth Group by 1.6% in the 3rd quarter. Vanguard Group Inc now owns 69,342,549 shares of the healthcare conglomerate’s stock valued at $18,447,892,000 after purchasing an additional 1,073,505 shares during the last quarter. FMR LLC increased its stake in shares of UnitedHealth Group by 2.6% in the 3rd quarter. FMR LLC now owns 63,247,814 shares of the healthcare conglomerate’s stock valued at $16,826,448,000 after purchasing an additional 1,625,459 shares during the last quarter. Capital International Investors increased its stake in shares of UnitedHealth Group by 223.0% in the 3rd quarter. Capital International Investors now owns 16,319,843 shares of the healthcare conglomerate’s stock valued at $4,341,731,000 after purchasing an additional 11,267,910 shares during the last quarter. Finally, Morgan Stanley grew its position in UnitedHealth Group by 18.1% during the 3rd quarter. Morgan Stanley now owns 6,495,072 shares of the healthcare conglomerate’s stock worth $1,727,948,000 after acquiring an additional 996,515 shares during the last quarter. 85.31% of the stock is currently owned by institutional investors.

TRADEMARK VIOLATION WARNING: “William C. Ballard, Jr. Sells 5,000 Shares of UnitedHealth Group Inc (UNH) Stock” was first posted by Chaffey Breeze and is owned by of Chaffey Breeze. If you are reading this piece on another domain, it was stolen and reposted in violation of U.S. and international trademark and copyright law. The original version of this piece can be read at https://www.chaffeybreeze.com/2019/01/23/william-c-ballard-jr-sells-5000-shares-of-unitedhealth-group-inc-unh-stock.html.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Recommended Story: What is the Federal Reserve?

Insider Buying and Selling by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply